1. P635: TARGETING THE ONE-CARBON METABOLISM AS NOVEL THERAPEUTIC STRATEGY IN CHRONIC LYMPHOCYTIC LEUKEMIA. (23rd June 2022) Authors: Viry, E.; Largeot, A.; Gonder, S.; Chemlal, S.; Kiweler, N.; Meiser, J.; Helleday, T.; Moussay, E.; Paggetti, J. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 533 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. S137: SMALL EXTRACELLULAR VESICLES IN THE LEUKEMIA MICROENVIRONMENT SUSTAIN CLL PROGRESSION BY HAMPERING T CELL-MEDIATED ANTI-TUMOR IMMUNITY. (23rd June 2022) Authors: Gargiulo, E.; Viry, E.; Morande, P. E.; Largeot, A.; Gonder, S.; Xian, F.; Ioannou, N.; Benzarti, M.; Kleine Borgmann, F.; Mittelbronn, M.; Dittmar, G.; Nazarov, P. V.; Meiser, J.; Stamatopoulos, B.; Ramsay, A. G.; Moussay, E.; Paggetti, J. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The role of IRG1 in atherosclerosis. (August 2022) Authors: Haase, L.; Neises, L.; Kiweler, N.; Adrian, I.; Meiser, J.; Schneider, J. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗